The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 17, 2021. Long positions only.
- Positions
- 6
- No 13F data for Q4 2020
- Portfolio value
- $1.04B
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NGMNGM Biopharmaceuticals Inc | COM | 15,396,116 | $447.6M | 42.9% | – | – | History |
| NRIXNurix Therapeutics, Inc. | COM | 5,383,333 | $167.4M | 16.0% | – | – | History |
| RVMDRevolution Medicines, Inc. | COM | 3,580,252 | $164.3M | 15.7% | – | – | History |
| ORICOric Pharmaceuticals, Inc. | COM | 4,768,181 | $116.8M | 11.2% | – | – | History |
| RAPTRAPT Therapeutics, Inc. | COM | 3,885,679 | $86.3M | 8.3% | – | – | History |
| CNSTConstellation Pharmaceuticals Inc | COM | 2,626,631 | $61.4M | 5.9% | – | – | History |